an-intact-pericardium-ischemic-rodent-model

An Intact Pericardium Ischemic Rodent Model

This protocol has shown that the pericardium and its contents play an essential anti-fibrotic role in the ischemic rodent model (coronary ligation to ...

Cumming School of Medicine

Empagliflozin, an SGLT2 inhibitor, has shown remarkable reductions in cardiovascular mortality and heart failure admissions (EMPA-REG OUTCOME). However, the mechanism underlying the heart failure protective effects of empagliflozin remains largely unknown. Cardiac fibroblasts play an integral role in the progression of structural cardiac remodelling and heart failure, in part, by regulating extracellular matrix (ECM) homeostasis. The objective of this study was to determine if empagliflozin has a direct effect on human cardiac myofibroblast-mediated ECM remodelling.

Direct Effects of Empagliflozin on Extracellular Matrix Remodelling in Human Cardiac Myofibroblasts: Novel Translational Clues to Explain EMPA-REG OUTCOME Results.

Post-operative adhesions affect patients undergoing all types of surgeries. They are associated with serious complications, including higher risk of morbidity and mortality. Given increased hospitalization, longer operative times, and longer length of hospital stay, post-surgical adhesions also pose a great financial burden. Although our knowledge of some of the underlying mechanisms driving adhesion formation has significantly improved over the past two decades, literature has yet to fully explain the pathogenesis and etiology of post-surgical adhesions. As a result, finding an ideal preventative strategy and leveraging appropriate tissue engineering strategies has proven to be difficult. Different products have been developed and enjoyed various levels of success along the translational tissue engineering research spectrum, but their clinical translation has been limited. Herein, we comprehensively review the agents and products that have been developed to mitigate post-operative adhesion formation. We also assess emerging strategies that aid in facilitating precision and personalized medicine to improve outcomes for patients and our healthcare system.

Jameson A. Dundas

Section of Cardiac Surgery,
Department of Cardiac Sciences,
Libin Cardiovascular Institute,
Section of Cardiac Surgery, Department of Cardiac Sciences, Libin Cardiovascular Institute

Cumming School of Medicine

An Intact Pericardium Ischemic Rodent Model

Jameson A. Dundas

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Section of Cardiac Surgery,Department of Cardiac Sciences,Libin Cardiovascular Institute,Section of Cardiac Surgery, Department of Cardiac Sciences, Libin Cardiovascular Institute

Cumming School of Medicine

An Intact Pericardium Ischemic Rodent Model

Section of Cardiac Surgery,
Department of Cardiac Sciences,
Libin Cardiovascular Institute,
Section of Cardiac Surgery, Department of Cardiac Sciences, Libin Cardiovascular Institute